Search

Meeting Coverage:

European Society of Cataract and Refractive Surgeons Meeting

ESCRS: 2024

Biological Markers for Progressive Keratoconus

Pooja Khamar, MS, FRCS(NN), PhD

Show Description +

Pooja Khamar, MS, FRCS(NN), PhD, reviews her presentation from the ESCRS annual meeting on the role of biomarkers and genetics in progressive keratoconus, dry eye disease, and other inflammatory conditions. She stresses the importance of targeting these inflammatory biomarkers to improve treatment outcomes and manage systemic genetic conditions.

Posted: 9/23/2024

Keywords:

Keratoconus

•

Dry Eye Disease

•

inflammatory biomarkers

Up Next

Update on the Second Global Consensus on Keratoconus

Update on the Second Global Consensus on Keratoconus

Farhad Hafezi, MD, PhD, FARVO

$Keratorefractive Lenticule Extraction$

Keratorefractive Lenticule Extraction

Béatrice Cochener-Lamard, MD, PhD

What Is the Future of Glaucoma Management?

What Is the Future of Glaucoma Management?

Henny Beckers, MD, PhD FEBOphth

Advances in Ocular Imaging to Assess and Predict Visual Function

Advances in Ocular Imaging to Assess and Predict Visual Function

Pablo Artal, PhD

$Refractive Surgery Technique Modifications$

Refractive Surgery Technique Modifications

Renato Ambrosio, Jr., MD, PhD

Should Monofocal Plus Be the New Standard Monofocal IOL?

Should Monofocal Plus Be the New Standard Monofocal IOL?

Vance Thompson, MD

Immediate Sequential Bilateral Minimonovision Approach With EDOF Lenses

Immediate Sequential Bilateral Minimonovision Approach With EDOF Lenses

Ruth Lapid Gortzak, MD, PhD

Sustainability in Ophthalmology

Sustainability in Ophthalmology

Ben LaHood, MD, MBChB(Dist), PGDipOphth(Dist), FRANZCO

Back to All Videos

Biological Markers for Progressive Keratoconus

Pooja Khamar, MS, FRCS(NN), PhD

Pooja Khamar, MS, FRCS(NN), PhD, reviews her presentation from the ESCRS annual meeting on the role of biomarkers and genetics in progressive keratoconus, dry eye disease, and other inflammatory conditions. She stresses the importance of targeting these inflammatory biomarkers to improve treatment outcomes and manage systemic genetic conditions.

Posted: 9/23/2024

Keywords:

Keratoconus

•

Dry Eye Disease

•

inflammatory biomarkers

Please log in to leave a comment.

More From ESCRS: 2024 Coverage

Should Monofocal Plus Be the New Standard Monofocal IOL?

Should Monofocal Plus Be the New Standard Monofocal IOL?

Vance Thompson, MD

Immediate Sequential Bilateral Minimonovision Approach With EDOF Lenses

Immediate Sequential Bilateral Minimonovision Approach With EDOF Lenses

Ruth Lapid Gortzak, MD, PhD

Sustainability in Ophthalmology

Sustainability in Ophthalmology

Ben LaHood, MD, MBChB(Dist), PGDipOphth(Dist), FRANZCO

Update on the Second Global Consensus on Keratoconus

Update on the Second Global Consensus on Keratoconus

Farhad Hafezi, MD, PhD, FARVO

Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ESCRS: 2024.